3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Other
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
51
Leukemia
28
Burkitt Lymphoma
6
Recurrence
5
Lymphoma
5
Leukemia, Biphenotypic, Acute
3
Lymphoma, T-Cell
2
Lymphoma, Extranodal NK-T-Cell
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm, Residual
1
Mucositis
1
Lymphoproliferative Disorders
1
Leukemia, T-Cell
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphoid
1
Immunoproliferative Disorders
1
Fallopian Tube Neoplasms
1
Drug-Related Side Effects and Adverse Reactions
1
Down Syndrome
1
Dendritic Cell Sarcoma, Interdigitating
1
Blast Crisis
1
Interventions
Radiotherapy
6
Fibroblast Growth Factor 7
4
Injections
3
Drug Therapy
3
Cisplatin
3
Water
2
Propolis
2
Mouthwashes
2
Morphine
2
Methotrexate
2
Melphalan
2
Low-Level Light Therapy
2
Interleukin 1 Receptor Antagonist Protein
2
Gabapentin
2
Cryotherapy
2
peppermint oil
1
pegaspargase
1
oxycodone-acetaminophen
1
nelarabine
1
kang-lai-te
1
glucarpidase
1
fludarabine phosphate
1
fish oil triglycerides
1
cyclohexaneacetic acid
1
calcium phosphate
1
brilacidin
1
anise oil
1
amlexanox
1
aluminum hydroxide, magnesium hydroxide, drug combination
1
acetaminophen, hydrocodone drug combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Mucositis
×
pegaspargase
×
Clear all
NCT01085617
2025-03-30
UKALL14
University College, London
Completed